All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0622-ZP3328 | Anti-NKG2DL h(VHH1-VHH2-CD28-CD3ζ) Biepitopic CAR, pCDCAR1 | Human | VHH1-VHH2-CD28-CD3ζ | Lentiviral vector | T Cell | ||||
XS-0622-ZP3500 | Anti-NKG2DL h(VHH1-VHH2-4-1BB-CD3ζ) Biepitopic CAR, pCDCAR1 | VHH1-VHH2-4-1BB-CD3ζ | Lentiviral vector | T Cell | |||||
XS-0822-YF593 | Anti-Human NKG2DL (XW-593) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-593 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF594 | Anti-Human NKG2DL (XW-594) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-594 | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF733 | Anti-Human NKG2DL (NKG2D receptor) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | NKG2D receptor | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1653 | Anti-Human NKG2DL (NKG2D receptor) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | NKG2D receptor | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2573 | Anti-Human NKG2DL (NKG2D receptor) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | NKG2D receptor | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8981 | TS-Fluc Anti-Human NKG2DL scFv (NKG2D receptor) 41BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9390 | TS-Fluc Anti-Human NKG2DL scFv (NKG2D receptor) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-1122-YF6113 | Anti-NKG2DL (XW-593) h(CD28-CD3ζ) CAR, pAAV | Human | XW-593 | Mouse | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6114 | Anti-NKG2DL (XW-594) h(CD28-CD3ζ) CAR, pAAV | Human | XW-594 | Human | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7033 | Anti-NKG2DL (XW-593) h(41BB-CD3ζ) CAR, pAAV | Human | XW-593 | Mouse | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7034 | Anti-NKG2DL (XW-594) h(41BB-CD3ζ) CAR, pAAV | Human | XW-594 | Human | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7173 | Anti-NKG2DL (NKG2D receptor) h(41BB-CD3ζ) CAR, pAAV | Human | NKG2D receptor | Human | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7953 | Anti-NKG2DL (XW-593) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-593 | Mouse | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7954 | Anti-NKG2DL (XW-594) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-594 | Human | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF8093 | Anti-NKG2DL (NKG2D receptor) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | NKG2D receptor | Human | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-0123-ZP786 | Anti-NKG2DL (trNKG2D) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | trNKG2D | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP786 | Anti-NKG2DL (trNKG2D scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | trNKG2D | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0923-LX109 | Anti-hNKG2DL (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-78 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION